Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice

Anupama Chandramouli, Jiaqi Shi, Yongmei Feng, Hana Holubec, Renée M.shanas, Achyut K Bhattacharyya, Wenxin - Zheng, Mark A Nelson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The Cdc2L gene encodes for the cyclin-dependent kinase 11 (CDK11) protein. Loss of one allele of Cdc2L and reduced CDK11 expression has been observed in several cancers, implicating its association with carcinogenesis. To directly investigate the role of CDK11 in carcinogenesis, we first generated cdc2l haploinsufficient mice by gene trap technology and then studied the susceptibility of these gene-trapped (cdc2lGT) mice to chemical-mediated skin carcinogenesis in the 7,12-dimethylbenz[a]anthracene (DMBA)/ 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced two-stage skin carcinogenesis model. Wild-type and cdc2lGT mice were subjected to a single topical application of initiation by DMBA and promotion twice a week for 19 weeks with TPA. At 19 weeks, 70% of the cdc2lGT mice and 60% of the cdc2l+/+ mice developed benign papillomas. However, there was an overall 3-fold increase in the average number of tumors per mouse observed in cdc2lGT mice as compared with cdc2l+/+ mice. There was also an increased frequency of larger papillomas in cdc2lGT mice. By using the polymerase chain reaction-restriction fragment length polymorphism assay, we found A to T transversion mutations at the 61st codon of H-ras gene in the papilloma tissue of both cdc2lGT mice and cdc2l+/+ mice. Ki-67 staining revealed increased proliferation in the papillomas of cdc2lGT (77.75%) as compared with cdc2l+/+ (30.84%) tumors. These studies are the first to show that loss of one allele of cdc2l gene, encoding CDK11, facilitates DMBA/TPA-induced skin carcinogenesis in vivo.

Original languageEnglish (US)
Pages (from-to)2028-2035
Number of pages8
JournalCarcinogenesis
Volume28
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Haploinsufficiency
Skin Neoplasms
Genes
Cyclin-Dependent Kinases
Papilloma
Carcinogenesis
9,10-Dimethyl-1,2-benzanthracene
Tetradecanoylphorbol Acetate
Skin
Alleles
Neoplasms
ras Genes
Codon
Restriction Fragment Length Polymorphisms

ASJC Scopus subject areas

  • Cancer Research

Cite this

Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. / Chandramouli, Anupama; Shi, Jiaqi; Feng, Yongmei; Holubec, Hana; M.shanas, Renée; Bhattacharyya, Achyut K; Zheng, Wenxin -; Nelson, Mark A.

In: Carcinogenesis, Vol. 28, No. 9, 09.2007, p. 2028-2035.

Research output: Contribution to journalArticle

Chandramouli, Anupama ; Shi, Jiaqi ; Feng, Yongmei ; Holubec, Hana ; M.shanas, Renée ; Bhattacharyya, Achyut K ; Zheng, Wenxin - ; Nelson, Mark A. / Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. In: Carcinogenesis. 2007 ; Vol. 28, No. 9. pp. 2028-2035.
@article{7f2cc97fd2d4427eadf5fbe87a37b34c,
title = "Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice",
abstract = "The Cdc2L gene encodes for the cyclin-dependent kinase 11 (CDK11) protein. Loss of one allele of Cdc2L and reduced CDK11 expression has been observed in several cancers, implicating its association with carcinogenesis. To directly investigate the role of CDK11 in carcinogenesis, we first generated cdc2l haploinsufficient mice by gene trap technology and then studied the susceptibility of these gene-trapped (cdc2lGT) mice to chemical-mediated skin carcinogenesis in the 7,12-dimethylbenz[a]anthracene (DMBA)/ 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced two-stage skin carcinogenesis model. Wild-type and cdc2lGT mice were subjected to a single topical application of initiation by DMBA and promotion twice a week for 19 weeks with TPA. At 19 weeks, 70{\%} of the cdc2lGT mice and 60{\%} of the cdc2l+/+ mice developed benign papillomas. However, there was an overall 3-fold increase in the average number of tumors per mouse observed in cdc2lGT mice as compared with cdc2l+/+ mice. There was also an increased frequency of larger papillomas in cdc2lGT mice. By using the polymerase chain reaction-restriction fragment length polymorphism assay, we found A to T transversion mutations at the 61st codon of H-ras gene in the papilloma tissue of both cdc2lGT mice and cdc2l+/+ mice. Ki-67 staining revealed increased proliferation in the papillomas of cdc2lGT (77.75{\%}) as compared with cdc2l+/+ (30.84{\%}) tumors. These studies are the first to show that loss of one allele of cdc2l gene, encoding CDK11, facilitates DMBA/TPA-induced skin carcinogenesis in vivo.",
author = "Anupama Chandramouli and Jiaqi Shi and Yongmei Feng and Hana Holubec and Ren{\'e}e M.shanas and Bhattacharyya, {Achyut K} and Zheng, {Wenxin -} and Nelson, {Mark A}",
year = "2007",
month = "9",
doi = "10.1093/carcin/bgm066",
language = "English (US)",
volume = "28",
pages = "2028--2035",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice

AU - Chandramouli, Anupama

AU - Shi, Jiaqi

AU - Feng, Yongmei

AU - Holubec, Hana

AU - M.shanas, Renée

AU - Bhattacharyya, Achyut K

AU - Zheng, Wenxin -

AU - Nelson, Mark A

PY - 2007/9

Y1 - 2007/9

N2 - The Cdc2L gene encodes for the cyclin-dependent kinase 11 (CDK11) protein. Loss of one allele of Cdc2L and reduced CDK11 expression has been observed in several cancers, implicating its association with carcinogenesis. To directly investigate the role of CDK11 in carcinogenesis, we first generated cdc2l haploinsufficient mice by gene trap technology and then studied the susceptibility of these gene-trapped (cdc2lGT) mice to chemical-mediated skin carcinogenesis in the 7,12-dimethylbenz[a]anthracene (DMBA)/ 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced two-stage skin carcinogenesis model. Wild-type and cdc2lGT mice were subjected to a single topical application of initiation by DMBA and promotion twice a week for 19 weeks with TPA. At 19 weeks, 70% of the cdc2lGT mice and 60% of the cdc2l+/+ mice developed benign papillomas. However, there was an overall 3-fold increase in the average number of tumors per mouse observed in cdc2lGT mice as compared with cdc2l+/+ mice. There was also an increased frequency of larger papillomas in cdc2lGT mice. By using the polymerase chain reaction-restriction fragment length polymorphism assay, we found A to T transversion mutations at the 61st codon of H-ras gene in the papilloma tissue of both cdc2lGT mice and cdc2l+/+ mice. Ki-67 staining revealed increased proliferation in the papillomas of cdc2lGT (77.75%) as compared with cdc2l+/+ (30.84%) tumors. These studies are the first to show that loss of one allele of cdc2l gene, encoding CDK11, facilitates DMBA/TPA-induced skin carcinogenesis in vivo.

AB - The Cdc2L gene encodes for the cyclin-dependent kinase 11 (CDK11) protein. Loss of one allele of Cdc2L and reduced CDK11 expression has been observed in several cancers, implicating its association with carcinogenesis. To directly investigate the role of CDK11 in carcinogenesis, we first generated cdc2l haploinsufficient mice by gene trap technology and then studied the susceptibility of these gene-trapped (cdc2lGT) mice to chemical-mediated skin carcinogenesis in the 7,12-dimethylbenz[a]anthracene (DMBA)/ 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced two-stage skin carcinogenesis model. Wild-type and cdc2lGT mice were subjected to a single topical application of initiation by DMBA and promotion twice a week for 19 weeks with TPA. At 19 weeks, 70% of the cdc2lGT mice and 60% of the cdc2l+/+ mice developed benign papillomas. However, there was an overall 3-fold increase in the average number of tumors per mouse observed in cdc2lGT mice as compared with cdc2l+/+ mice. There was also an increased frequency of larger papillomas in cdc2lGT mice. By using the polymerase chain reaction-restriction fragment length polymorphism assay, we found A to T transversion mutations at the 61st codon of H-ras gene in the papilloma tissue of both cdc2lGT mice and cdc2l+/+ mice. Ki-67 staining revealed increased proliferation in the papillomas of cdc2lGT (77.75%) as compared with cdc2l+/+ (30.84%) tumors. These studies are the first to show that loss of one allele of cdc2l gene, encoding CDK11, facilitates DMBA/TPA-induced skin carcinogenesis in vivo.

UR - http://www.scopus.com/inward/record.url?scp=34547782947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547782947&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgm066

DO - 10.1093/carcin/bgm066

M3 - Article

C2 - 17389615

AN - SCOPUS:34547782947

VL - 28

SP - 2028

EP - 2035

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -